fda warning bpc-157 compounded Approval Status: Is It Approved for Human Use? Regeneration or Risk? A Narrative
Description
The ThermiSmooth treatment has been performed for several years, with no significant complications (beyond swelling and redness)
For people who experienced significant nausea during dose escalation, this strategy has genuine merit
While more human studies are needed, existing peptide research suggests strong potential for improving flexibility, reducing discomfort, and helping the body heal more efficiently
In a retrospective trial[5] of 16 patients with chronic knee pain, 91.6% of those receiving intra-articular BPC-157 experienced significant pain relief, far surpassing acetaminophens effect size of 0.13
